Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The objective of this protocol is to add an extension period to provide continuous therapy and to collect safety data (collection of adverse events serious (SAE) or not (AE)) of French patients who completed the international CACZ885G2301E1 study in France.
Critère d'inclusion
- Systemic Juvenile Idiopathic Arthritis (SJIA) with active systemic manifestations